Deshail Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -1865.84%
- Ebitda 94.68%
- Net Worth -16.07%
- Total Assets 201.94%
About Deshail Biotech
Deshail Biotech Private Limited (DBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 May 2021 (Three years and eight months 18 days old ). Its registered office is in Raipur, Chattisgarh, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Soni and Harsha Vashistha serve as directors at the Company.
Company Details
-
Location
Raipur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U11100CT2021PTC011621
-
Company No.
011621
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 May 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Deshail Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Soni
|
Director | 19-May-2021 | Current |
|
Harsha Vashistha
|
Director | 22-Nov-2022 | Current |
Financial Performance of Deshail Biotech.
Deshail Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1865.84% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deshail Biotech?
Unlock access to Deshail Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Fuai Technologies Private LimitedHarsha Vashistha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Deshail Biotech?
Deshail Biotech has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deshail Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deshail Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
